Track topics on Twitter Track topics that are important to you
- Company Reports Third Quarter 2017 Revenue of $6.1 Million, Up 55% Compared to Last Year -
- Continued Progress on Building a Consumer Products Platform Around TRU NIAGEN™-
IRVINE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE)
Original Article: ChromaDex Reports Third Quarter 2017 Financial ResultsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...